The EU’s strategic rebalancing of research partnerships with China

In 2026, one of Europe’s most ambitious scientific ventures, Horizon Europe, a seven-year, roughly €93 billion framework dedicated to research and innovation, underwent a quiet but significant transformation. 

What had once been an open invitation to researchers across the globe now carries a more guarded tenor. 

In critical areas such as artificial intelligence, semiconductors, quantum technologies, and biotechnology, organisations based in China are no longer automatically eligible to receive EU funding, a sharp deviation from earlier years when Chinese participation was possible, albeit under evolving conditions. 

This change is neither arbitrary nor purely technical. It reflects the culmination of years of negotiation and strategic signalling in Brussels. 

According to the European Commission’s own international cooperation guidance, cooperation with third countries like China has always been conditional; Chinese researchers may contribute, but they are required to enter as Associated Partners and often must bring their own funding where EU ...